En Es
Categories

Randox Laboratories

Randox Laboratories

Provides global diagnostic solutions for hospital laboratories, forensic laboratories, research laboratories, pharmaceutical companies and veterinary clinics, including clinical chemistry and immunoassay analysers, high quality reagents, and quality control material.
Gold member
Products Covid-19NewsSummaryEventsWhitepappers
Close

Covid-19 Randox Laboratories

Clinical Laboratory

SARS-CoV-2 Controls
Qnostics’ SARS-CoV-2(SCV2) Q Controls

Qnostics’ SARS-CoV-2(SCV2) Q Controls are single use positive controls intended to support the validation, verification and performance monitoring of molecular assays used in the testing of SARS-CoV-2 (COVID-19). Qnostics controls contain the entire SARS-CoV-2 genome meaning they are compatible with the majority of commercial and in-house assays. As whole pathogen controls they target the whole viral genome, including CDC and WHO consensus sequences.
More details

SARS-CoV-2 Antibody Control
Acusera SARS-CoV-2 Antibody Control

The Acusera SARS-CoV-2 Antibody Control comprises both reactive and non-reactive controls for anti SARS-CoV-2, and will support assay validation and routine performance monitoring of serological assays for COVID-19. Conveniently supplied in a liquid ready-to-use format with a 30-day open vial stability, waste is kept to a minimum. As a true third party control, independent performance assessment is guaranteed.
More details

SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing

Qnostics SARS-CoV-2 Typing are reactive and non-reactive controls intended for use with in-vitro assays for the determination of spike antibodies to SARS-CoV-2. These controls can be used on various analyzers, making them useful in determining precision of testing systems and allows for performance monitoring of multiple test systems.
More details

SARS-CoV-2 Rapid Test
Vivalytic SARS-CoV-2 Rapid 39 Minute Test

The Vivalytic SARS-CoV-2 Rapid 39 Minute Test is a real time CE marked PCR test cartridge, providing clear and concise results in a timely manner, direct at the point of care. This enables the patient to take the recommended safety precautions without delay. The new SARS-CoV-2 pooling test will allow users to test up to 160 samples a day and has sensitivity of 98% and a specificity of 100% – a world’s first! Released in collaboration with Bosch, the Vivalytic SARS-CoV-2 Rapid 39 Minute Test is not only a rapid testing solution for the detection of SARS-CoV-2 (COVID-19) but an accelerated mass testing solution to effectively and efficiently monitor and detect viral infection from the offset with an aim of minimizing the rise in infections globally.
More details

SARS-CoV-2 (COVID-19) Test
Vivalytic Viral Respiratory Tract Infection (VRI) Array

The Vivalytic Viral Respiratory Tract Infection Array Detecting SARS-CoV-2 (COVID-19) can identify SARS-CoV-2 (COVID-19) and differentiate it from nine other respiratory infections with similar symptoms, including influenza and all known coronaviruses. One of the world’s first multiplex molecular diagnostic tests to meet the COVID-19 testing recommendations of the World Health Organization (WHO) and the Centers for Disease Control (CDC), it provides a more comprehensive respiratory screening which enables precise and informed treatment decisions to be made.
More details

SARS-CoV-2 Pooling Test
Extensive SARS-CoV-2 Pooling

The Extensive SARS-CoV-2 Pooling is a rapid real-time PCR test cartridge, providing clear and concise results in a timely manner, direct at the point of care on the Vivalytic analyzer. The SARS-CoV-2 pooling test with lollipop swab allows for the screening of up to 15 patient samples and produces results in less than 45 minutes. Ideal for mass testing, the pooling could be done at the level of a ward, medical specialty, social bubble, or group of colleagues. It has potential for use in other settings, such as pre-operative screening, schools and universities, prisons, nursing homes, primary care, and large workplaces.
More details

SARS-CoV-2 Pooling Test
Vivalytic SARS-CoV-2 Pooling Test

The Vivalytic SARS-CoV-2 Pooling (COVID-19) is a rapid real time PCR test cartridge, providing clear and concise results in a timely manner, direct at the point of care to enable the patient to take the recommended safety precautions without delay. The new SARS-CoV-2 pooling test will allow users to test up to 160 samples a day and has sensitivity of 98% and a specificity of 100% – a world’s first. Highly sensitive assays allow for laboratories to accurately detect low positive samples, enabling for effective identification of positive COVID-19 cases in a timely manner.
More details

SARS-CoV-2 IgG (RBD & NP) Test
SARS-CoV-2 IgG (RBD & NP) Array

The Randox SARS-CoV-2 IgG (RBD & NP) array utilizes patented biochip technology to simultaneously detect IgG antibodies against both leading COVID-19 diagnostic antigens; Spike Receptor Binding Domain (RBD) and Nucleocapsid protein (NP). Maximum sensitivity is ensured through detection of antibodies against both proteins making the assay superior compared to other commercially available serology tests where false negative results are common. Measurement of both RBD and NP IgG antibodies also provides an opportunity to discriminate vaccinated versus naturally infected individuals based on leading vaccine candidates.
More details

Cytokine Arrays
Cytokine Arrays

Randox offer testing solutions for a comprehensive range of cytokines, cytokine receptors and growth factors designed to assist with COVID-19 risk stratification, monitoring of treatment efficacy and recovery. Utilizing patented Biochip technology up to 12 cytokines and growth factors may be detected simultaneously from a single patient sample.
More details

Coronavirus COVID-19 Array
Coronavirus COVID-19 Array

The Randox COVID-19 Array targets genes for SARS-CoV-2 and for sarbecovirus (SARS, SARS like, SARS-CoV-2) and are in line with WHO and CDC recommendations. These genes represent conserved regions of the genome and have been chosen due to their sensitivity and specificity. Suitable for use with the Evidence Investigator from Randox, the Lo-Plex Molecular Assay for SARS-CoV-2 (COVID-19) detects both SARS-CoV-2 and Sarbecovirus (confirmatory target), to report COVID-19 positive patient samples.
More details

Coronavirus Array
Extended Coronavirus Array

Suitable for use with the Evidence Investigator from Randox, the Extended Coronavirus Array comprises six strains of coronavirus, including SARS-CoV-2. The wider panel delivers a more comprehensive respiratory screen allowing differentiation between COVID-19 and other respiratory viruses with similar symptoms, ultimately enabling better treatment decisions to be made.
More details

Critical Care

SARS-CoV-2 Rapid Test
Vivalytic SARS-CoV-2 Rapid 39 Minute Test

The Vivalytic SARS-CoV-2 Rapid 39 Minute Test is a real time CE marked PCR test cartridge, providing clear and concise results in a timely manner, direct at the point of care. This enables the patient to take the recommended safety precautions without delay. The new SARS-CoV-2 pooling test will allow users to test up to 160 samples a day and has sensitivity of 98% and a specificity of 100% – a world’s first! Released in collaboration with Bosch, the Vivalytic SARS-CoV-2 Rapid 39 Minute Test is not only a rapid testing solution for the detection of SARS-CoV-2 (COVID-19) but an accelerated mass testing solution to effectively and efficiently monitor and detect viral infection from the offset with an aim of minimizing the rise in infections globally.
More details

SARS-CoV-2 (COVID-19) Test
Vivalytic Viral Respiratory Tract Infection (VRI) Array

The Vivalytic Viral Respiratory Tract Infection Array Detecting SARS-CoV-2 (COVID-19) can identify SARS-CoV-2 (COVID-19) and differentiate it from nine other respiratory infections with similar symptoms, including influenza and all known coronaviruses. One of the world’s first multiplex molecular diagnostic tests to meet the COVID-19 testing recommendations of the World Health Organization (WHO) and the Centers for Disease Control (CDC), it provides a more comprehensive respiratory screening which enables precise and informed treatment decisions to be made.
More details

SARS-CoV-2 Pooling Test
Extensive SARS-CoV-2 Pooling

The Extensive SARS-CoV-2 Pooling is a rapid real-time PCR test cartridge, providing clear and concise results in a timely manner, direct at the point of care on the Vivalytic analyzer. The SARS-CoV-2 pooling test with lollipop swab allows for the screening of up to 15 patient samples and produces results in less than 45 minutes. Ideal for mass testing, the pooling could be done at the level of a ward, medical specialty, social bubble, or group of colleagues. It has potential for use in other settings, such as pre-operative screening, schools and universities, prisons, nursing homes, primary care, and large workplaces.
More details

Point-Of-Care Testing

SARS-CoV-2 Rapid Test
Vivalytic SARS-CoV-2 Rapid 39 Minute Test

The Vivalytic SARS-CoV-2 Rapid 39 Minute Test is a real time CE marked PCR test cartridge, providing clear and concise results in a timely manner, direct at the point of care. This enables the patient to take the recommended safety precautions without delay. The new SARS-CoV-2 pooling test will allow users to test up to 160 samples a day and has sensitivity of 98% and a specificity of 100% – a world’s first! Released in collaboration with Bosch, the Vivalytic SARS-CoV-2 Rapid 39 Minute Test is not only a rapid testing solution for the detection of SARS-CoV-2 (COVID-19) but an accelerated mass testing solution to effectively and efficiently monitor and detect viral infection from the offset with an aim of minimizing the rise in infections globally.
More details

SARS-CoV-2 (COVID-19) Test
Vivalytic Viral Respiratory Tract Infection (VRI) Array

The Vivalytic Viral Respiratory Tract Infection Array Detecting SARS-CoV-2 (COVID-19) can identify SARS-CoV-2 (COVID-19) and differentiate it from nine other respiratory infections with similar symptoms, including influenza and all known coronaviruses. One of the world’s first multiplex molecular diagnostic tests to meet the COVID-19 testing recommendations of the World Health Organization (WHO) and the Centers for Disease Control (CDC), it provides a more comprehensive respiratory screening which enables precise and informed treatment decisions to be made.
More details
Close

News of Randox Laboratories

Randox Acquires Microfluidic Tools and Impedence Flow Cytometer Developer Cellix Limited

22 Jun 2023
Randox Acquires Microfluidic Tools and Impedence Flow Cytometer Developer Cellix Limited
Randox Laboratories, a global diagnostics company and diagnostic biochips developer, has completed its acquisition of Cellix Limited, a developer of microfluidic tools and impedance flow cytometers for cell analysis.
Read More

Randox and Bosch Healthcare Collaboratively Combat COVID-19 with Game-Changing Partnership

28 Oct 2020
Randox and Bosch Healthcare Collaboratively Combat COVID-19 with Game-Changing Partnership
The game-changing partnership between Randox Laboratories (Crumlin, UK) and Bosch Healthcare (Waiblingen, Germany) continues to alter the testing landscape and capabilities of both laboratory and non-laboratory settings for rapidly detecting COVID-19.
Read More

Randox and Bosch Partner to Launch Molecular Diagnostics Platform

01 Mar 2018
Randox and Bosch Partner to Launch Molecular Diagnostics Platform
Global healthcare diagnostics manufacturer Randox Laboratories has partnered with Bosch Healthcare Solutions GmbH to launch Vivalytic, an all-in-one fully automated solution for molecular diagnostics.
Read More
Close

About Randox Laboratories

Number of Employees: 1000+
Year of Establishment: 1982
Provides global diagnostic solutions for hospital laboratories, forensic laboratories, research laboratories, pharmaceutical companies and veterinary clinics, including clinical chemistry and immunoassay analysers, high quality reagents, and quality control material.
Close

Events Randox Laboratories

AACC 2022

Chicago, Illinois

AACC 2022

July 24 - 28, 2022
The AACC Annual Scientific Meeting & Clinical Lab Expo
gives laboratory medicine professionals the opportunity to: Connect with
global leaders in clinical chemistry, molecular diagnostics, mass spectrometry,
translational medicine, lab management, and other areas of breaking science
in laboratory medicine.

Randox is delighted to announce we will be exhibiting at AACC Annual
Scientific Meeting and Clinical Lab EXPO.

Visit booth #1419 at the McCormick Place Convention Center in Chicago, July
24-28 where we will be discussing innovative diagnostic products and
solutions, as well as showcasing our pioneering technologies.
Chicago, Illinois
Stand #: 1419
Website
Close

Whitepappers Randox Laboratories

EDUCATIONAL GUIDE: Commutability

Whitepaper Approximately 70% of all clinical decisions are based on laboratory test results reinforcing the need for quality throughout the laboratory. Poor laboratory quality can lead to unreliable test results ultimately leading to misdiagnosis, inappropriate treatment and may even impact on the quality of life for the patient. With this in mind we need to ask ourselves “just how important is quality to a laboratory?” – The answer to this question should always be very.
Improving Laboratory Performance Through Quality Control

Whitepaper Anyone working in a laboratory will understand the importance of quality control (QC). QC is the process used to detect errors in order to ensure the reliability and accuracy of patient test results.Without QC, laboratory errors could go unnoticed potentially resulting in misdiagnosis and inappropriate or delayed treatment, all of which could be life-threatening for the patient.
EDUCATIONAL GUIDE: The Role of EQA in Quality Control

Whitepaper Quality Control (QC) is a vital process for laboratories to monitor the accuracy and precision of patient sample testing. Without QC, laboratory errors could go undetected potentially resulting in misdiagnosis and inappropriate or delayed treatment, all of which could be life threatening for the patient.
Improving Laboratory Performance Through Quality Control

Whitepaper Quality Control (QC) is vitally important in ensuring accurate patient test results, but it can be a time consuming process for laboratory staff. In an industry where budgets and resources are increasingly under pressure, laboratories are continuously looking for ways to ensure high levels of throughput without compromising on accuracy.
EDUCATIONAL GUIDE: How to Measure Uncertainty

Whitepaper The laboratory shall determine measurement uncertainty for each measurement procedure, in the examination phases used to report measured quantity values on patients’ samples. The laboratory shall define the performance requirements for the measurement uncertainty of each measurement procedure and regularly review estimates of measurement uncertainty.
EDUCATIONAL GUIDE Troubleshooting QC Errors

Whitepaper So you ran QC this morning and realised that one of your analytes has been flagged as “out-of-control”, what do you do next? Do you ignore the warning and continue patient testing, repeat the control until it’s within range or do you halt patient testing and investigate the source of the error?
EDUCATIONAL GUIDE: Designing an Appropriate QC Procedure

Whitepaper It is easy to get caught up in an abundance of QC statistics and forget the fundamental reason why QC exists in the first instance. QC is about detecting errors and ensuring that the results you produce are accurate and reliable. All QC procedures should focus on reducing the risk of harm to the patient. We are not examining statistics; we are examining real patients, real results and real lives. Around 70% of all medical decisions are based on laboratory results, which is why it is of utmost importance that each and every laboratory, has a well-designed QC procedure in place.
EDUCATIONAL GUIDE: ISO 15189:2012 Accreditation Guide

Whitepaper Approximately 70% of clinical decisions are based on laboratory test results. Poor laboratory quality can result in unreliable test results ultimately leading to misdiagnosis, inappropriate treatment and may even impact the overall quality of life for the patient. The importance of quality medical services is recognised globally with several bodies existing internationally including ISO (International Organisation for Standardisation) who have developed a set of guidelines and quality systems to ensure reliable test results - ISO 15189:2012. This guide will outline what you need to consider and implement with regards to quality control to gain and maintain ISO 15189:2012 Accreditation.
EDUCATIONAL GUIDE: The Cost of Poor Quality in the Clinical Lab

Whitepaper In the clinical laboratory, the term ‘Quality’ refers to the standard of one lab’s results compared to others. Generally, every lab or test system could be made more efficient, and labs seeking to achieve a good standard of quality will need to engage in ongoing process evaluation and improvement. Good quality is like a reputation; it takes a long time to build, but it can be ruined in an instant.

Recently updated

Xylazine Immunoassay Test
Xylazine ELISA

The newly-established Xylazine ELISA is the first immunoassay test in the world for this drug of abuse and is available on the Evidence MultiSTAT analyzer. Evidence MultiSTAT is designed to work across a variety of matrices including blood, and oral fluid, and simultaneously screens for up to 29 drugs of abuse from a single sample in less than 31 minutes.
More details

MRSA/MSSA Rapid Test
Vivalytic MRSA/MSSA Rapid Test

The Vivalytic MRSA/SA test cartridge is a rapid qualitative RT-PCR that identifies and differentiates between methicillin-resistant Staphylococcus aureus (MRSA), methicillin-sensitive Staphylococcus aureus (MSSA), and methicillin-resistant coagulase-negative Staphylococci (MRCoNS). It quickly diagnoses MRSA infection within 53 minutes, enabling timely antibiotic treatment and prevention of complications.
More details

Ultra-Low PSA Control
Prostate-Specific Antigen Control

Prostate-specific Antigen (PSA) control is intended to aid testing for indications of prostate cancer and other prostate conditions such as prostatitis and benign prostatic hyperplasia. Manufactured using human serum to ensure a matrix like patient sample, the control has been optimized for use with Roche systems, but is suitable for use across a variety of other platforms.
More details

Critical Care

STI Test
Vivalytic Sexually Transmitted Infection (STI) Array

The Vivalytic Sexually Transmitted Infection (STI) array is the broadest multiplex cartridge-based STI test on the market simultaneously detecting seven bacterial, two viral and one protozoan infection for a comprehensive sexual health profile. Designed to offer a complete sexual health profile with an aim of prevention and control, the Vivalytic STI array can be used to diagnose existing infections whilst any identifying co-infections.
More details

SARS-CoV-2 Pooling Test
Extensive SARS-CoV-2 Pooling

The Extensive SARS-CoV-2 Pooling is a rapid real-time PCR test cartridge, providing clear and concise results in a timely manner, direct at the point of care on the Vivalytic analyzer. The SARS-CoV-2 pooling test with lollipop swab allows for the screening of up to 15 patient samples and produces results in less than 45 minutes. Ideal for mass testing, the pooling could be done at the level of a ward, medical specialty, social bubble, or group of colleagues. It has potential for use in other settings, such as pre-operative screening, schools and universities, prisons, nursing homes, primary care, and large workplaces.
More details

SARS-CoV-2 Rapid Test
Vivalytic SARS-CoV-2 Rapid 39 Minute Test

The Vivalytic SARS-CoV-2 Rapid 39 Minute Test is a real time CE marked PCR test cartridge, providing clear and concise results in a timely manner, direct at the point of care. This enables the patient to take the recommended safety precautions without delay. The new SARS-CoV-2 pooling test will allow users to test up to 160 samples a day and has sensitivity of 98% and a specificity of 100% – a world’s first! Released in collaboration with Bosch, the Vivalytic SARS-CoV-2 Rapid 39 Minute Test is not only a rapid testing solution for the detection of SARS-CoV-2 (COVID-19) but an accelerated mass testing solution to effectively and efficiently monitor and detect viral infection from the offset with an aim of minimizing the rise in infections globally.
More details

SARS-CoV-2 (COVID-19) Test
Vivalytic Viral Respiratory Tract Infection (VRI) Array

The Vivalytic Viral Respiratory Tract Infection Array Detecting SARS-CoV-2 (COVID-19) can identify SARS-CoV-2 (COVID-19) and differentiate it from nine other respiratory infections with similar symptoms, including influenza and all known coronaviruses. One of the world’s first multiplex molecular diagnostic tests to meet the COVID-19 testing recommendations of the World Health Organization (WHO) and the Centers for Disease Control (CDC), it provides a more comprehensive respiratory screening which enables precise and informed treatment decisions to be made.
More details

Home Care

Diabetes Control
Acusera HbA1c

The Acusera HbA1c offers lyophilized control with assayed values provided for HPLC and a wide range of chemistry analyzers. It provides 100% human whole blood control, which helps minimize matrix effects reducing lot-to-lot variations between batches.
More details

Clinical Laboratory

Xylazine Immunoassay Test
Xylazine ELISA

The newly-established Xylazine ELISA is the first immunoassay test in the world for this drug of abuse and is available on the Evidence MultiSTAT analyzer. Evidence MultiSTAT is designed to work across a variety of matrices including blood, and oral fluid, and simultaneously screens for up to 29 drugs of abuse from a single sample in less than 31 minutes.
More details

MRSA/MSSA Rapid Test
Vivalytic MRSA/MSSA Rapid Test

The Vivalytic MRSA/SA test cartridge is a rapid qualitative RT-PCR that identifies and differentiates between methicillin-resistant Staphylococcus aureus (MRSA), methicillin-sensitive Staphylococcus aureus (MSSA), and methicillin-resistant coagulase-negative Staphylococci (MRCoNS). It quickly diagnoses MRSA infection within 53 minutes, enabling timely antibiotic treatment and prevention of complications.
More details

Ultra-Low PSA Control
Prostate-Specific Antigen Control

Prostate-specific Antigen (PSA) control is intended to aid testing for indications of prostate cancer and other prostate conditions such as prostatitis and benign prostatic hyperplasia. Manufactured using human serum to ensure a matrix like patient sample, the control has been optimized for use with Roche systems, but is suitable for use across a variety of other platforms.
More details

BNP Control
BNP1-32

A true third-party solution, BNP1-32 is a new Acusera BNP Control designed for use with in vitro diagnostics assays for the quantitative determination of BNP in human serum and plasma. The BNP control delivers an unbiased, independent assessment of analytical performance, helping to ensure accurate and reliable patient testing for BNP.
More details

Lipoprotein(a) Assay
Lipoprotein(a)

The Randox Lipoprotein(a) assay is intended for the quantitative in vitro determination of Lp(a) in serum or plasma, and is suitable for automated, semi-automated and manual use. The assay is standardized to the WHO/IFCC reference material (IFCC SRM 2B) and is closest in terms of agreement to the ELISA reference material. A dedicated five-point calibrator and control are available, accurately reflecting the heterogeneity of the apo(a) isoforms, while the measuring units are in nmol/l which is more uniformed.
More details

Laboratory Quality Control
Acusera

Randox Acusera laboratory quality control is designed to monitor an IVD instruments response in the detection of HIL samples. The control can be utilized in laboratory interference testing to assist in improving error detection of pre-analytical errors affecting clinical chemistry testing.
More details

Hormonal Test
Endocrine Array

The Randox Endocrine Array has been developed for the simultaneous determination of four hormones important in human homeostasis from a single sample. Applicable to both fully automated and semi-automated Evidence analyzers, it is suitable for human serum and plasma samples, it requires a small sample volume and delivers excellent analytical performance.
More details

Thyroid Function Test
Thyroid Arrays

Randox Thyroid Arrays designed for accurate thyroid function testing enable simultaneous measurement of thyroid hormones in a single patient human serum sample. Applicable to both fully automated and semi-automated Evidence analyzers, it offers fast throughput and excellent analytical performance.
More details

CKD Test
Chronic Kidney Disease (CKD) Array I (7-plex)

The Randox Chronic Kidney Disease (CKD) arrays utilize patented Biochip Technology to improve patient risk stratification while monitoring the effectiveness of treatment. Developed for the Evidence Investigator, a semi-automated benchtop immunoassay analyzer, it enables early multiplex detection of CKD from a single sample for earlier intervention through treatment and preventing further kidney damage.
More details

STI Test
Vivalytic Sexually Transmitted Infection (STI) Array

The Vivalytic Sexually Transmitted Infection (STI) array is the broadest multiplex cartridge-based STI test on the market simultaneously detecting seven bacterial, two viral and one protozoan infection for a comprehensive sexual health profile. Designed to offer a complete sexual health profile with an aim of prevention and control, the Vivalytic STI array can be used to diagnose existing infections whilst any identifying co-infections.
More details

ApoE4 Blood Test
ApoE4 Array (EV4113)

The Randox ApoE4 Array is a rapid and highly sensitive blood test for the rapid identification of Alzheimer’s disease risk by facilitating direct ApoE4 genotyping without the need for molecular genotyping. Developed for the Evidence Investigator, a semi-automated benchtop immunoassay analyzer, the research use-only product simultaneously measures both total ApoE and ApoE4 protein levels directly from a plasma sample.
More details

Portable POC Reader
VeraSTAT

The VeraSTAT is a simple, accurate, portable point of care device which delivers rapid results via the use of patented cathodic electrochemiluminescence technology (C-ECL). Designed with the aim of offering users the next generation of rapid diagnosis, the VeraSTAT eliminates the requirement to send samples to a laboratory and instead returns results in as little as six minutes when and where required.
More details

SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing

Qnostics SARS-CoV-2 Typing are reactive and non-reactive controls intended for use with in-vitro assays for the determination of spike antibodies to SARS-CoV-2. These controls can be used on various analyzers, making them useful in determining precision of testing systems and allows for performance monitoring of multiple test systems.
More details

SARS-CoV-2 Pooling Test
Extensive SARS-CoV-2 Pooling

The Extensive SARS-CoV-2 Pooling is a rapid real-time PCR test cartridge, providing clear and concise results in a timely manner, direct at the point of care on the Vivalytic analyzer. The SARS-CoV-2 pooling test with lollipop swab allows for the screening of up to 15 patient samples and produces results in less than 45 minutes. Ideal for mass testing, the pooling could be done at the level of a ward, medical specialty, social bubble, or group of colleagues. It has potential for use in other settings, such as pre-operative screening, schools and universities, prisons, nursing homes, primary care, and large workplaces.
More details

Fully Automated Batch Immunoanalyzer
Evidence+

The Evidence+ is a fully automated batch immunoanalyzer for simultaneously detecting multiple drugs and drug metabolites from a single patient sample. It offers the world’s most advanced toxicology testing menu and is capable of analyzing an array of sample types including blood, urine, oral fluid and a range of forensic toxicology matrices.
More details

SARS-CoV-2 Pooling Test
Vivalytic SARS-CoV-2 Pooling Test

The Vivalytic SARS-CoV-2 Pooling (COVID-19) is a rapid real time PCR test cartridge, providing clear and concise results in a timely manner, direct at the point of care to enable the patient to take the recommended safety precautions without delay. The new SARS-CoV-2 pooling test will allow users to test up to 160 samples a day and has sensitivity of 98% and a specificity of 100% – a world’s first. Highly sensitive assays allow for laboratories to accurately detect low positive samples, enabling for effective identification of positive COVID-19 cases in a timely manner.
More details

SARS-CoV-2 Antibody Control
Acusera SARS-CoV-2 Antibody Control

The Acusera SARS-CoV-2 Antibody Control comprises both reactive and non-reactive controls for anti SARS-CoV-2, and will support assay validation and routine performance monitoring of serological assays for COVID-19. Conveniently supplied in a liquid ready-to-use format with a 30-day open vial stability, waste is kept to a minimum. As a true third party control, independent performance assessment is guaranteed.
More details

Molecular & Immunoassay Diagnostic Analyzer
Randox Discovery

The Randox Discovery is a molecular & immunoassay diagnostic analyzer capable of consolidating the normal workload of multiple laboratories, into one compact benchtop platform. It uses Randox patented Biochip Technology that allows simultaneous detection of hundreds of targets from a single patient sample.
More details

SARS-CoV-2 Rapid Test
Vivalytic SARS-CoV-2 Rapid 39 Minute Test

The Vivalytic SARS-CoV-2 Rapid 39 Minute Test is a real time CE marked PCR test cartridge, providing clear and concise results in a timely manner, direct at the point of care. This enables the patient to take the recommended safety precautions without delay. The new SARS-CoV-2 pooling test will allow users to test up to 160 samples a day and has sensitivity of 98% and a specificity of 100% – a world’s first! Released in collaboration with Bosch, the Vivalytic SARS-CoV-2 Rapid 39 Minute Test is not only a rapid testing solution for the detection of SARS-CoV-2 (COVID-19) but an accelerated mass testing solution to effectively and efficiently monitor and detect viral infection from the offset with an aim of minimizing the rise in infections globally.
More details

SARS-CoV-2 IgG (RBD & NP) Test
SARS-CoV-2 IgG (RBD & NP) Array

The Randox SARS-CoV-2 IgG (RBD & NP) array utilizes patented biochip technology to simultaneously detect IgG antibodies against both leading COVID-19 diagnostic antigens; Spike Receptor Binding Domain (RBD) and Nucleocapsid protein (NP). Maximum sensitivity is ensured through detection of antibodies against both proteins making the assay superior compared to other commercially available serology tests where false negative results are common. Measurement of both RBD and NP IgG antibodies also provides an opportunity to discriminate vaccinated versus naturally infected individuals based on leading vaccine candidates.
More details

Coronavirus Array
Extended Coronavirus Array

Suitable for use with the Evidence Investigator from Randox, the Extended Coronavirus Array comprises six strains of coronavirus, including SARS-CoV-2. The wider panel delivers a more comprehensive respiratory screen allowing differentiation between COVID-19 and other respiratory viruses with similar symptoms, ultimately enabling better treatment decisions to be made.
More details

Coronavirus COVID-19 Array
Coronavirus COVID-19 Array

The Randox COVID-19 Array targets genes for SARS-CoV-2 and for sarbecovirus (SARS, SARS like, SARS-CoV-2) and are in line with WHO and CDC recommendations. These genes represent conserved regions of the genome and have been chosen due to their sensitivity and specificity. Suitable for use with the Evidence Investigator from Randox, the Lo-Plex Molecular Assay for SARS-CoV-2 (COVID-19) detects both SARS-CoV-2 and Sarbecovirus (confirmatory target), to report COVID-19 positive patient samples.
More details

SARS-CoV-2 (COVID-19) Test
Vivalytic Viral Respiratory Tract Infection (VRI) Array

The Vivalytic Viral Respiratory Tract Infection Array Detecting SARS-CoV-2 (COVID-19) can identify SARS-CoV-2 (COVID-19) and differentiate it from nine other respiratory infections with similar symptoms, including influenza and all known coronaviruses. One of the world’s first multiplex molecular diagnostic tests to meet the COVID-19 testing recommendations of the World Health Organization (WHO) and the Centers for Disease Control (CDC), it provides a more comprehensive respiratory screening which enables precise and informed treatment decisions to be made.
More details

Cytokine Arrays
Cytokine Arrays

Randox offer testing solutions for a comprehensive range of cytokines, cytokine receptors and growth factors designed to assist with COVID-19 risk stratification, monitoring of treatment efficacy and recovery. Utilizing patented Biochip technology up to 12 cytokines and growth factors may be detected simultaneously from a single patient sample.
More details

PCR Analyzer
Vivalytic

Vivalytic is the easiest-to-use and most-comprehensive multiplex PCR platform on the market and provides the broadest range of test options ever seen for its size. Using Randox-patented Biochip Array Technology, the device also supports single-plex and low-plex testing, simplifying the processes for otherwise-complex laboratory test procedures.
More details

SARS-CoV-2 Controls
Qnostics’ SARS-CoV-2(SCV2) Q Controls

Qnostics’ SARS-CoV-2(SCV2) Q Controls are single use positive controls intended to support the validation, verification and performance monitoring of molecular assays used in the testing of SARS-CoV-2 (COVID-19). Qnostics controls contain the entire SARS-CoV-2 genome meaning they are compatible with the majority of commercial and in-house assays. As whole pathogen controls they target the whole viral genome, including CDC and WHO consensus sequences.
More details

Linearity Verifiers
Acusera Verify

The Acusera Verify range of instrument-dedicated, liquid calibration verifiers are designed to challenge the entire Analytical Measuring Range, while helping to meet CLIA requirements and remaining convenient to use. The linearity materials cover a wide range of testing, including, CRP, RF, lipids, therapeutic drugs, esoterics, and more, and are supplied in a liquid format in varying levels with user convenience in mind.
More details

sdLDL-C Biochemistry Assay
sdLDL-C

The sdLDL-C automated biochemistry assay is intended for measuring sdLDL-C levels with applications for a wide range of analyzers. It uses the clearance method which produces results in as little as 10 minutes, facilitating faster patient diagnosis and treatment plan implementation.
More details

Laboratory Software
Acusera 24•7

The Acusera 24•7 laboratory software assists laboratories in the effective management of QC data and has the unique ability to provide peer group data instantly in real-time, as well as automatically generate advanced QC statistics, including Sigma Scores and Uncertainty of Measurement. In addition to providing labs with comprehensive reports and interactive charts such as Levey-Jennings and Histograms, the software is able to speed up troubleshooting and aid laboratories as they strive for accreditation.
More details

Cholesterol Assay
sLDL Cholesterol Assay

The Randox sLDL Cholesterol assay utilizes the “Denka Seiken” method which produces results in 10 minutes and correlates extremely well with the gold standard, ultracentrifugation method. The conveniently supplied liquid ready-to-use assay is stable to expiry when stored at +2 to +8°C and has a wide measuring of 4 – 100mg/dl, comfortably detecting levels outside of the healthy range.
More details

Auto Immunoanalyser
Evidence

The Evidence fully automated immunoanalyser for rapid multiplex testing combines the latest technological advances along with an innovative system design. It has a throughput of up to 3,960 tests per hour, a capacity of 180 samples and can screen up to 44 analytes per biochip.
More details

Rapid Diagnostic Test
Multiplex Array

The Multiplex Array simultaneously detects 22 viral and bacterial pathogens from the upper and lower respiratory tract and enables identification of secondary or multiple infections. It provides clinicians with a comprehensive infection profile for the patient enabling rapid and accurate diagnosis without the need for secondary or confirmatory testing to inform clinical treatment decisions.
More details

Benchtop Immunoanalyser
Evidence Investigator

The Evidence Investigator is a semi-automated benchtop immunoanalyser that uses multiplexing technology for research, clinical, forensic, molecular, and veterinary testing. With a throughput of up to 2,376 tests per hour, up to 44 analytes screened per biochip and wide test menu, it is suitable for medium throughput laboratories
More details

Biochip Immunoanalyzer
Evidence Evolution

The Evidence Evolution can process any required workflow including batch analysis, STAT samples, and can run 2,640 tests/hour. Features include continuous sample and reagent loading, automated on-board sample dilution, sample data entry, and a walkaway time of two hours.
More details

Semi-auto Chemistry Analyzer
RX misano

The RX misano semi-automated clinical chemistry analyzer features a sleek ergonomic design, responsive touch-screen display and intuitive user-friendly software for test menu personalization for ease of use. It offers the option to run flow cell or cuvette mode to ensure maximum chemistries can be performed on one system and uses flow cell washing to avoid contamination for ensuring accurate results.
More details

Biochip Immunoanalyser
Evidence MultiSTAT

The Evidence MultiSTAT is an automated analyzer that enables on-site simultaneous detection of up to 21 classical, prescription and synthetic drugs from a single sample. Designed to work across a variety of matrices, the multi-analyte testing platform provides a complete immunoassay profile within minutes and requires minimal sample preparation.
More details

Clinical Chemistry Analyzer
RX imola

The RX imola is a fully automated benchtop clinical chemistry analyzer with random access and STAT sampling functionality that delivers up to 400 photometric tests per hour and 240 ISE tests per hour at a minimum reaction volume of 150µl. It has a dual reagent probe that minimizes carry over, and five-speed mixing arms that eliminate foaming, making it ideal for medium to large throughput laboratories.
More details

Clinical Chemistry Analyzer
RX modena

The RX modena high volume, floor standing, fully automated clinical chemistry analyzer can run up to 1,200 tests per hour, with unique HbA1c testing abilities and features interactive touch-screen technology. It allows 800 photometric tests per hour and 200 ISE tests per hour, along with twin reagent micropipette and dedicated sample pipette for crash protection and clot detection.
More details

Clinical Chemistry Analyzer
RX Monaco

The RX Monaco fully automated clinical chemistry analyzer offers an optimal throughput of 170 tests per hour with STAT priority function, and provides 66 cooled, user-defined, reagent and sample positions. It can be easily integrated into any laboratory setting with the option of a floor standing unit if bench-top space is limited and is ideal for smaller laboratories.
More details

Clinical Chemistry Analyzer
RX daytona+

The RX daytona+ bench-top, fully automated, random access clinical chemistry analyzer performs routine & specialized testing and emergency STAT sampling, offering 450 tests per hour, including ISE, and 270 photometric tests per hour. It has a comprehensive test menu, a low water consumption of 5L per hour, and barcode readers for both sample and reagent identification.
More details

Immunoassay Control
Acusera Immunoassay Premium Plus

Impressively covering 54 analytes including tumour markers, therapeutic drugs and routine immunoassay tests, the Acusera Immunoassay Premium Plus control has been uniquely designed to eliminate the need for four or more controls, dramatically reducing costs and time. The added advantage of ultra low levels of Ferritin, Vitamin B12 and TSH will ensure accurate performance at key decision levels and further reduce the number of controls required. Assayed target values are supplied for 51 analytes in this true third party control. Manufactured using 100% human serum, this control is designed to directly mimic a patient sample, reducing costly shifts when reagent batch is changed.
More details

Immunoassay Controls
Acusera Specialty Control 1

The Acusera Immunoassay Specialty Control 1 is an assayed Quality Control, suitable for use with most immunoassay analyzers. The multianalyte control offers assigned values for all 10 parameters, and contains clinically relevant levels of Vitamin D.
More details

Diabetes Control
Acusera HbA1c

The Acusera HbA1c offers lyophilized control with assayed values provided for HPLC and a wide range of chemistry analyzers. It provides 100% human whole blood control, which helps minimize matrix effects reducing lot-to-lot variations between batches.
More details

Cardiac Assay
H-FABP

The H-FABP assay is a biomarker of myocardial ischemia, and is detectable as early as within 30 minutes of release after an ischemic episode. The assay can speed up treatment, and the rapid return to baseline within 24 hours offers potential use with patients with suspected reinfarction.
More details

Point-Of-Care Testing

Xylazine Immunoassay Test
Xylazine ELISA

The newly-established Xylazine ELISA is the first immunoassay test in the world for this drug of abuse and is available on the Evidence MultiSTAT analyzer. Evidence MultiSTAT is designed to work across a variety of matrices including blood, and oral fluid, and simultaneously screens for up to 29 drugs of abuse from a single sample in less than 31 minutes.
More details

MRSA/MSSA Rapid Test
Vivalytic MRSA/MSSA Rapid Test

The Vivalytic MRSA/SA test cartridge is a rapid qualitative RT-PCR that identifies and differentiates between methicillin-resistant Staphylococcus aureus (MRSA), methicillin-sensitive Staphylococcus aureus (MSSA), and methicillin-resistant coagulase-negative Staphylococci (MRCoNS). It quickly diagnoses MRSA infection within 53 minutes, enabling timely antibiotic treatment and prevention of complications.
More details

STI Test
Vivalytic Sexually Transmitted Infection (STI) Array

The Vivalytic Sexually Transmitted Infection (STI) array is the broadest multiplex cartridge-based STI test on the market simultaneously detecting seven bacterial, two viral and one protozoan infection for a comprehensive sexual health profile. Designed to offer a complete sexual health profile with an aim of prevention and control, the Vivalytic STI array can be used to diagnose existing infections whilst any identifying co-infections.
More details

Portable POC Reader
VeraSTAT

The VeraSTAT is a simple, accurate, portable point of care device which delivers rapid results via the use of patented cathodic electrochemiluminescence technology (C-ECL). Designed with the aim of offering users the next generation of rapid diagnosis, the VeraSTAT eliminates the requirement to send samples to a laboratory and instead returns results in as little as six minutes when and where required.
More details

SARS-CoV-2 Rapid Test
Vivalytic SARS-CoV-2 Rapid 39 Minute Test

The Vivalytic SARS-CoV-2 Rapid 39 Minute Test is a real time CE marked PCR test cartridge, providing clear and concise results in a timely manner, direct at the point of care. This enables the patient to take the recommended safety precautions without delay. The new SARS-CoV-2 pooling test will allow users to test up to 160 samples a day and has sensitivity of 98% and a specificity of 100% – a world’s first! Released in collaboration with Bosch, the Vivalytic SARS-CoV-2 Rapid 39 Minute Test is not only a rapid testing solution for the detection of SARS-CoV-2 (COVID-19) but an accelerated mass testing solution to effectively and efficiently monitor and detect viral infection from the offset with an aim of minimizing the rise in infections globally.
More details

SARS-CoV-2 (COVID-19) Test
Vivalytic Viral Respiratory Tract Infection (VRI) Array

The Vivalytic Viral Respiratory Tract Infection Array Detecting SARS-CoV-2 (COVID-19) can identify SARS-CoV-2 (COVID-19) and differentiate it from nine other respiratory infections with similar symptoms, including influenza and all known coronaviruses. One of the world’s first multiplex molecular diagnostic tests to meet the COVID-19 testing recommendations of the World Health Organization (WHO) and the Centers for Disease Control (CDC), it provides a more comprehensive respiratory screening which enables precise and informed treatment decisions to be made.
More details

PCR Analyzer
Vivalytic

Vivalytic is the easiest-to-use and most-comprehensive multiplex PCR platform on the market and provides the broadest range of test options ever seen for its size. Using Randox-patented Biochip Array Technology, the device also supports single-plex and low-plex testing, simplifying the processes for otherwise-complex laboratory test procedures.
More details
Copyright © 2000-2024 TradeMed.com. All rights reserved. | Terms And Conditions